An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients with Hepatic Dominant Ocular Melanoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Delcath Systems, Inc.
Start Date
August 30, 2022
End Date
September 18, 2027
Administered By
Duke Cancer Institute
Awarded By
Delcath Systems, Inc.
Start Date
August 30, 2022
End Date
September 18, 2027